VECTICAL Drug Patent Profile
✉ Email this page to a colleague
When do Vectical patents expire, and what generic alternatives are available?
Vectical is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vectical
A generic version of VECTICAL was approved as calcitriol by TEVA on October 12th, 2001.
Summary for VECTICAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 4 |
| Patent Applications: | 4,684 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VECTICAL |
| What excipients (inactive ingredients) are in VECTICAL? | VECTICAL excipients list |
| DailyMed Link: | VECTICAL at DailyMed |
Recent Clinical Trials for VECTICAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, San Francisco | Phase 4 |
| Emer, Jason, M.D. | Phase 4 |
| Galderma Laboratories | Phase 4 |
Pharmacology for VECTICAL
| Drug Class | Vitamin D3 Analog |
Anatomical Therapeutic Chemical (ATC) Classes for VECTICAL
US Patents and Regulatory Information for VECTICAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | VECTICAL | calcitriol | OINTMENT;TOPICAL | 022087-001 | Jan 23, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
